Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson

BACKGROUND: Immune checkpoint inhibitors (ICPIs) are gaining increasing popularity as an efficacious treatment for advanced malignancies. ICPI treatment can be complicated by diarrhea and colitis. Systemic steroids are the first line treatment. Infliximab is reserved for severe refractory cases. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yinghong, Abu-Sbeih, Hamzah, Mao, Emily, Ali, Noman, Ali, Faisal Shaukat, Qiao, Wei, Lum, Phillip, Raju, Gottumukkala, Shuttlesworth, Gladis, Stroehlein, John, Diab, Adi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946546/
https://www.ncbi.nlm.nih.gov/pubmed/29747688
http://dx.doi.org/10.1186/s40425-018-0346-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946546/
https://www.ncbi.nlm.nih.gov/pubmed/29747688
http://dx.doi.org/10.1186/s40425-018-0346-6

Ejemplares similares